精神在线您现在的位置:  >> NaSSA合理应用文献研究平台 >> 文献服务 >> 抑郁、焦虑与睡眠障碍 >> 综述文献 >> 文献正文
抗抑郁药和睡眠:一篇文献定性回顾
文献服务】【告诉好友】【打印此文】【关闭窗口
题目(Title)Antidepressants and sleep: a qualitative review of the literature

著者(Authors)】 Wilson S, Argyropoulos S.
来源(Source)】 Drugs. 2005;65(7):927-47
关键词(Keywords)】 sleep,Antidepressants

摘要(Abstract)】:

Most antidepressants change sleep; in particular, they alter the physiological patterns of sleep stages recorded overnight with EEG and other physiological measures. These effects are greatest and most consistent on rapid eye movement (REM) sleep, and tend to be in the opposite direction to the sleep abnormalities found in major depression, but are usually of greater degree. Reductions in the amount of REM sleep and increases in REM sleep onset latency are seen after taking antidepressants, both in healthy volunteers and in depressed patients. Antidepressants that increase serotonin function by blocking reuptake or by inhibiting metabolism have the greatest effect on REM sleep. The decrease in amount of REM sleep appears to be greatest early in treatment, and gradually diminishes during long-term treatment, except after monoamine oxidase inhibitors when REM sleep is often absent for many months. Sleep initiation and maintenance are also affected by antidepressants, but the effects are much less consistent between drugs. Some antidepressants such as clomipramine and the selective serotonin receptor inhibitors (SSRIs), particularly fluoxetine, are sleep-disturbing early in treatment and some others such as amitriptyline and the newer serotonin 5-HT2-receptor antagonists are sleep promoting. However, these effects are fairly short-lived and there are very few significant differences between drugs after a few weeks of treatment. In general, the objectively measured sleep of depressed patients improves during 3-4 weeks of effective antidepressant treatment with most agents, as does their subjective impression of their sleep. Sleep improvement earlier in treatment may be an important clinical goal in some patients, perhaps when insomnia is particularly distressing, or to ensure compliance. In these patients, the choice of a safely used and effective antidepressant which improves sleep in short term is indicated. Patients with other sleep disorders such as restless legs syndrome and REM sleep behaviour disorder should be identified before choosing a treatment, as some antidepressants worsen these conditions. Conversely, there is evidence that some antidepressants may be useful in the treatment of sleep disorders such as night terrors.


  • 上一篇文献: 没有了
  • 下一篇文献:

  • 相关文献
    5-羟色胺转运体基因启动子多态性对双相障碍完全睡眠剥夺效应的影响
    交互式电讯记录不同剂量给药方案下米氮平对病人警觉和睡眠的影响
    米氮平对抑郁症患者睡眠多导图变量的影响
    情绪障碍患者的睡眠及生物节律
    外伤后应激障碍病人的睡眠紊乱,流行病学、影响和处理方法
    米氮平引起帕金森病人快速动眼期睡眠行为障碍
    来自国家药物滥用调查(1996-2001)的分析数据:与治疗睡眠问题药物有关的医生和患者因素
    抗抑郁药和性功能障碍
    First effective drug for sleep disorder identified
    交互式电讯记录不同剂量给药方案下米氮平对病人警觉和睡眠的影响
    米氮平对于抑郁症病人睡眠连续性和结构急性效应的初步研究
    米氮平对于睡眠影响的由青年健康志愿者参加的安慰剂对照双盲研究
    抑郁症、抗抑郁药和性功能障碍



    精神在线网 复旦大学医学院精神卫生学系 合办
    本站专业医学信息和服务仅供中国医疗专业人士参考

    © 精神在线网 PsyCard.Com
    精神/心理医学专业信息网络平台、博客、论坛
    全站文章索引-SiteMap